Completed NA INTERVENTIONAL 2-arm NCT01110252

Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease (COPD-01)

Unicentric Study Protocol of Cell Therapy in Chronic Obstructive Pulmonary Disease

Sponsor: Instituto de Molestias Cardiovasculares

Conditions Chronic Obstructive Pulmonary Disease Pulmonary Emphysema

Interventions Stem cells stimulation stem cells collection stem cells infusion

Updated 8 times since 2017 Last updated: Feb 22, 2012 Started: May 31, 2009 Primary completion: Oct 31, 2010 Completion: Nov 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema and is currently completed. Instituto de Molestias Cardiovasculares leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Dec 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto de Molestias Cardiovasculares
Laboratório de Genética Humana e Terapia Celular, Unesp - Assis
UPECLIN HC FM Botucatu Unesp

Data source: UPECLIN HC FM Botucatu Unesp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Assis, Brazil